Genetic markers in the CSF2RB gene associated with an adverse hematological response to drugs

Details for Australian Patent Application No. 2006213677 (hide)

Owner PGXhealth, LLC

Inventors Gerson, Stanton; Athanasiou, Maria

Agent Blake Dawson Waldron Patent Services

Pub. Number AU-A-2006213677

PCT Pub. Number WO2006/086748

Priority 60/651,834 09.02.05 US

Filing date 9 February 2006

Wipo publication date 17 August 2006

International Classifications

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/086748 Priority application(s): WO2006/086748

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213685-Multi-part implant for open wedge knee osteotomies

2006213673-Formulations for ocular treatment